BRCA1 and familial pancreatic carcinoma: Furthermore, recent studies have reported that BRCA1/2 pathogenic variants potentially contribute to FPC and that the frequency of BRCA1/2, PALB2, and ATM variants in all pancreatic cancers is 7% [2–4].